Why is "Primary peritoneal carcinoma" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-05-21 19:18:08
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Primary_peritoneal_carcinoma entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-05-21 and was most recently seen on 2026-05-21.
Wikipedia Overview
Primary peritoneal cancer or carcinoma is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma, and psammomacarcinoma. It was historically classified under "carcinoma of unknown primary" (CUP). Primary peritoneal cancer is a cancer of the cells lining the peritoneum, or abdominal cavity. It usually affects women and is diagnosed after the age of 60; it very rarely affects men.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Keytruda With Paclitaxel Approved for Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma - Clinical Oncology News
-
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma - Yahoo Finance
-
FDA Approves Pembrolizumab Combo for Platinum-Resistant Ovarian Cancer - Oncology News Central
-
PD-L1 IHC 22C3 pharmDx Nets Companion Diagnostic Approval for Pembrolizumab in Ovarian Cancer - OncLive
-
Pembrolizumab-Based Regimen Approved for Platinum-Resistant Ovarian Cancer - Medical Professionals Reference
-
FDA Approves Pembrolizumab/Chemo in Platinum-Resistant GYN Indications - CancerNetwork
-
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC) - Business Wire
-
Case report: Germline BRCA 2 mutation in primary peritoneal carcinoma: a rare malignancy - Frontiers
-
Primary Peritoneal Carcinoma: A Rare Malignancy Presenting a Diagnostic Challenge - Cureus
-
A Rare Case of Primary Peritoneal Carcinoma With Large Bowel Metastasis - Cureus
-
Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR) - nature.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.